$365 Million is the total value of New Leaf Venture Partners, L.L.C.'s 20 reported holdings in Q1 2019. The portfolio turnover from Q4 2018 to Q1 2019 was 40.0% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| DCPH | DECIPHERA PHARMACEUTICALS INC | $95,257,000 | +10.6% | 4,104,140 | 0.0% | 26.10% | +10.4% | |
| PRNB | PRINCIPIA BIOPHARMA INC | $89,274,000 | +24.1% | 2,625,713 | 0.0% | 24.46% | +23.9% | |
| ARVN | ARVINAS INC | $33,698,000 | +14.9% | 2,283,048 | 0.0% | 9.23% | +14.7% | |
| HARP | New | HARPOON THERAPEUTICS INC | $27,666,000 | – | 2,921,405 | +100.0% | 7.58% | – |
| STIM | NEURONETICS INC | $23,533,000 | -21.2% | 1,543,115 | 0.0% | 6.45% | -21.3% | |
| ALEC | New | ALECTOR INC | $14,747,000 | – | 787,769 | +100.0% | 4.04% | – |
| APTX | APTYNIX INC | $13,325,000 | -75.5% | 3,290,079 | 0.0% | 3.65% | -75.6% | |
| ITRM | ITERUM THERAPEUTICS PLC | $11,537,000 | +58.1% | 1,456,303 | 0.0% | 3.16% | +57.8% | |
| OBSV | OBSEVA SA | $11,517,000 | +1.0% | 900,501 | 0.0% | 3.16% | +0.9% | |
| SRRA | SIERRA ONCOLOGY INC | $8,585,000 | +29.5% | 5,020,446 | 0.0% | 2.35% | +29.3% | |
| UMRX | UNUM THERAPEUTICS INC | $7,882,000 | -0.2% | 1,795,545 | 0.0% | 2.16% | -0.4% | |
| VSAR | ARAVIVE INC | $6,833,000 | +100.0% | 970,659 | 0.0% | 1.87% | +99.6% | |
| AVRO | AVROBIO INC | $4,753,000 | +32.4% | 215,550 | 0.0% | 1.30% | +32.2% | |
| CRNX | CRINETICS PHARMACEUTICALS INC | $3,817,000 | -24.1% | 167,700 | 0.0% | 1.05% | -24.2% | |
| NERV | MINERVA NEUROSCIENCES INC | $3,327,000 | +16.6% | 423,300 | 0.0% | 0.91% | +16.5% | |
| AFMD | Sell | AFFIMED N V | $3,078,000 | -45.0% | 732,774 | -59.3% | 0.84% | -45.2% |
| CMRX | CHIMERIX INC | $2,835,000 | -18.3% | 1,350,000 | 0.0% | 0.78% | -18.5% | |
| CHMA | New | CHIASMA INC | $2,080,000 | – | 400,000 | +100.0% | 0.57% | – |
| New | PDS BIOTECHNOLOGY CORP | $868,000 | – | 117,242 | +100.0% | 0.24% | – | |
| AVEO | AVEO PHARMACEUTICALS INC | $330,000 | -48.7% | 402,118 | 0.0% | 0.09% | -49.2% | |
| EDGE | Exit | EDGE THERAPEUTICS INC | $0 | – | -2,344,868 | -100.0% | -0.21% | – |
| PRTO | Exit | PROTEON THERAPEUTICS INC | $0 | – | -1,523,200 | -100.0% | -0.95% | – |
| CRSP | Exit | CRISPR THERAPEUTICS AGnamen akt | $0 | – | -444,708 | -100.0% | -3.49% | – |
| WVE | Exit | WAVE LIFE SCIENCES LTD | $0 | – | -425,429 | -100.0% | -4.91% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR/A filed 2019-06-04
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| DECIPHERA THERAPEUTICS INC | 25 | Q3 2023 | 44.4% |
| CHIMERIX INC | 25 | Q1 2023 | 20.9% |
| SIERRA ONCOLOGY INC | 22 | Q2 2022 | 14.9% |
| ARVINAS INC | 21 | Q3 2023 | 44.8% |
| CRINETICS PHARMACEUTICALS INC | 21 | Q3 2023 | 11.4% |
| OBSEVA SA | 20 | Q4 2021 | 8.5% |
| AVROBIO INC | 20 | Q1 2023 | 1.7% |
| HARPOON THERAPEUTICS INC | 19 | Q3 2023 | 20.0% |
| ALECTOR INC | 19 | Q3 2023 | 4.6% |
| ITERUM THERAPEUTICS PLC | 18 | Q3 2022 | 3.8% |
View New Leaf Venture Partners, L.L.C.'s complete holdings history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-02-14 |
| 13F-HR | 2023-11-14 |
| 13F-HR | 2023-08-10 |
| 13F-HR | 2023-05-11 |
| 13F-HR | 2023-02-06 |
| 13F-HR | 2022-11-10 |
| 13F-HR | 2022-08-09 |
| 13F-HR | 2022-05-06 |
| 13F-HR | 2022-02-11 |
| 13F-HR | 2021-11-12 |
View New Leaf Venture Partners, L.L.C.'s complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.